ENHERTU® Plus Pertuzumab Approved in the U.S. as First New Treatment in More Than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Br…

ENHERTU Plus Pertuzumab Approved in the U.S. for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer ...
Clinical Advisor

Turning the Tide: A Public Health Approach to Reduce Acute Lymphoblastic Leukemia

ALL is the most common childhood cancer, and cases are rising. Find out why this trend is paired with a remarkable 90% survival rate, and what public health action is needed next.
Medscape

Hypercalcemia of Malignancy: What Osteoporosis Drug Is Best?

A real-world cohort study showed no difference in efficacy between denosumab and bisphosphonates in treating inpatients with hypercalcemia of malignancy. “Prospective randomized trials are warranted ...
SciELO

Treatment of Hyperparathyroidism (SHPT)

Optimal PTH levels are not established for patients with CKD G3-5 (Evidence) 1.1 If serum PTH levels are progressively increasing or persistently above the reference value for the method, serum levels ...
SciELO

The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma

Paraneoplastic syndromes are a heterogeneous group of malignant diseases caused by events which involve endocrine, immune and metabolic aspects and whose symptoms vary according to the substance ...